IDWeek 2019 Data

New clinical outcomes data presented at IDWeek2019

ARLG RAPIDS-GN Trial at Mayo Clinic & UCLA -

The Randomized Clinical Trial Evaluating Clinical Impact of RAPid Identification and Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia (RAPIDS-GN)

R. Banerjee, L. Komarow, A. Virk, et al.

From the data
  • • For GN antibiotics: Mean (95% CI) 10.1h (4.8 - 15.4h) faster; Median 24.8h faster
  • • [Stewardship recommendations] made within 24h in 51% RAPID vs. 28% SOC, p‹.001

  • University of Iowa Hospitals and Clinics -

    Real-World Impact of Accelerate Pheno Implementation with Antimicrobial Stewardship Intervention

    P. Kinn, K. Percival, M. Edmond, et al.

    From the data
  • • Recommendations (bug-drug mismatch, de-escalation, dose optimization, and infectious disease consult) were accepted at a rate of 97.4%.
  • • Time from BC positivity to optimal therapy was 15.3 hours (Fig 2).

  • University of Arkansas for Medical Sciences -

    Impact of Accelerate Pheno Rapid Blood Culture Detection System with Real Time Notification versus Standard Antibiotic Stewardship on Clinical Outcomes in Bacteremic Patients

    C. Pearson, K. Lusardi, K. McCain, et al.

    From the data
  • • Total hospital length of stay, LOS (±SD) 11.9(10.6) historical vs. 9.5(9.8) intervention-1, p‹0.01
  • • Broad Gram-positive days (±SD) 4.9(5.1) historical vs. 3.9(4.7) intervention-2, p‹0.05
  • • Broad Gram-negative days (±SD) 6.2(7.6) historical vs. 4.7(6.7) intervention-2, p‹0.01
  • How a community hospital implemented fast susceptibilities to improve patient outcomes

    St. Tammany Parish Hospital
    Covington, GA